Stem Cell IV Therapeutics

This biologics is the only umbilical cord blood-derived stem cells nationwide with a FDA Investigational New Drug (IND), ensuring it meets the highest safety and efficacy standards for patients.

Umbilical cord blood stem cells repair damaged tissue, reduce inflammation, and restore cognitive and motor function. This therapy also plays a crucial role in pain management by reducing chronic inflammation, promoting tissue regeneration, and improving overall function, making it a breakthrough treatment for neuropathic and musculoskeletal pain.

This allograft is processed by Cord for Life®, a leader in umbilical cord blood banking for over 25 years, ensuring the highest quality, safety, and compliance. Cord for Life oversees endocrinology and serology testing, verifying each batch for purity, viability, and consistency.

This multi-potent umbilical cord blood stem cell allograft is naturally enriched with Natural Killer (NK) cells, which play a critical role in immune regulation and tumor suppression in cancer research. Unlike pluripotent stem cells, which are linked to uncontrolled cell growth, this allograft has been clinically tested and shown to pose no risk of tumorigenesis, making it safe for intravenous (IV) push administration.